2016
DOI: 10.1097/mnm.0000000000000412
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Liver (18)F-FDG uptake is consistent before and after neoadjuvant CRT therapy in patients with LARC. When assessing response to therapy and using liver metabolic activity to indicate background activity, BMI should be considered as it can influence liver metabolic activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 31 publications
1
2
0
Order By: Relevance
“…26 found higher SUV in men than women, while Demir et al . 25, like us, found SUL, but not SUW, to be higher in men. This sex difference indicates that correlations when the sexes are combined may be misleading.…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…26 found higher SUV in men than women, while Demir et al . 25, like us, found SUL, but not SUW, to be higher in men. This sex difference indicates that correlations when the sexes are combined may be misleading.…”
Section: Discussionsupporting
confidence: 72%
“…There is no significant correlation between lean body mass ( J LBM) estimated from the sex-specific formulae of Janmahasatian et al 25 and mean SUV ( J SUL mean ) calculated using J LBM as whole body metric in women (open circles; r =0.14) or in men (closed circles; r =−0.09), but there is a strong correlation when the sexes are combined into a single group ( r =0.44; P <0.0001). J LBM, Janmahasatian lean body mass; J SUL, Janmahasatian scaled to lean body mass; SUV, standardised uptake value.…”
Section: Resultsmentioning
confidence: 94%
“…Moreover, every treatment, be it surgery, irradiation treatment, or chemotherapy, not only attacks the tumour itself but also the surrounding tissue as well as the whole body. Therefore, therapy monitoring will not only catch the tumour response to therapy but also the whole body answer including immune reactions as well as metabolic changes [14]. Nevertheless, we can discriminate tumour viability from the immune reaction that will control the tumour or even destroy it.…”
Section: Biological Aspectsmentioning
confidence: 99%